Clinical Trial Update: Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study in women after preeclampsia is currently recruiting to investigate the sensitivity of Angiotensin II Type II receptors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preeclampsia

Snippet

Sponsor: Anna Stanhewicz, PhD | Conditions: Preeclampsia Postpartum | EARLY_Phase 1 | Status: RECRUITING